The Application of Jacobson Resonance

In 1996, almost two decades after discovering Jacobson Resonance, American physicist and biophysicist Dr. Jerry Jacobson received the necessary funding to apply his equation to a prototype device. The Jacobson Resonator™ as it was called was built by NASA engineers at the John C Stennis Space Center. It allowed scientists for the first time to accurately target and affect specific biological structures at their most fundamental atomic level.

It is important to understand that atoms which form molecules that comprise cells oscillate at different electromagnetic frequencies depending on the type of cell. Further, the atoms within healthy cells in a given biological structure (be it tissue, nerve, tendon, ligament, bone etc.) oscillate (or vibrate) at similar frequencies allowing for inter-atomic communication which provides the basis for biochemical events. When compared to healthy cells, damaged and diseased cells vibrate erratically and at different frequencies which impairs intercellular communication and the cells’ ability to heal.

By applying extremely precise electromagnetic fields calculated by the Jacobson Resonance equation, the Jacobson Resonator™ sought to target atoms within a given biological structure by reinforcing the naturally-occurring electromagnetic oscillations of healthy cells in order to renormalize the magnetic profile of damaged cells and help them return to the healthy cell state so that intercellular communication and homeostasis could be restored.

A landmark study lead by Saxena, A. (2003) at the Weill Medical College of Cornell University, and replicated at the Fairleigh Dickinson University, School of Natural Sciences indicated that electromagnetic fields calculated by Jacobson’s Resonance equation could renormalize mitochondria, Schewann cells, myelin sheaths, Golgi bodies, neurofilaments and microtubules in radial nerves of mice that were neurotoxin impaired. The results were the first to indicate a biological effect of electromagnetic fields in vivo on the restoration of the subcellular structures required for nerve impulse conduction and metabolism in nerves, and consequently a grip strength recovery from motor neuropathy, under controlled experimental conditions. This study is one of 10 key studies detailed in a publication by Dr. Jacobson entitled “The Relaxation Response”.

“Every generation seems to produce its own version of genius. Dr. Jacobson’s genius will be one that future generations will be discussing in the same conversation as Galileo, Einstein and Tesla. His work will one day change humanity. In my opinion, it has already begun.”

Benjamin J. Scherlag, PhD - Professor of Medicine, Regent’s Professor, Helen Webster Chair in Arrhythmia Research - Heart Rhythm Institute, University of Oklahoma Health Sciences Center

Clinical Magnetic Resonance Therapy (CMRT)

Over 20 years of intensive research conducted on Jacobson Resonators has helped establish electromagnetic field parameters and protocols utilized in the second generation commercialized CMRT System.

Clinical research began with basic science (in vitro and in vivo) and progressed to large double blind randomized placebo controlled studies conducted by Dr. Jacobson’s team as well as leading researchers from Universities and medical institutes in the United States, Europe and Asia.

Clinical research studies have been conducted in many areas including:

Atrial fibrillation

Chronic pain

Wound healing

Fibromyalgia

Parkinson's disease

Type 2 diabetes

Osteoarthritis

Alzheimer's disease

The effects of CMRT on specific biological structures and related medical conditions are extensively detailed under the Clinical Research section.

To conclude the Jacobson Resonance section we invite you to read: The human body as viewed in the past, present, and future. In this single page excerpt, Dr. Jacobson eloquently reflects upon the natural progression of medicine over the centuries from the macroscopic level through to the microscopic and now to the mesoscopic level of CMRT.

25 Years of R&D and Clinical Studies